Growth Metrics

Nexalin Technology (NXL) Revenue (2021 - 2026)

Nexalin Technology's quarterly Revenue came in at $14950.0 in Q1 2026, down 63.55% year-on-year from $41015.0 in Q1 2025, and down 91.3% quarter-over-quarter from $171895.0 in Q4 2025.

Nexalin Technology has reported Revenue for 6 years, with the latest figure at $14950.0 in Q1 2026.

  • For the quarter ending Q1 2026, Revenue fell 63.55% year-over-year to $14950.0; the trailing twelve-month figure through Mar 2026 stood at $275582.0 (up 110.26% YoY), and the FY2025 full-year result was $301647.0, up 78.78% from the prior year.
  • Revenue for Q1 2026 stood at $14950.0, down from $171895.0 in the prior quarter.
  • The five-year high for Revenue was $545323.0 in Q3 2022, with the low at $14950.0 in Q1 2026.
  • Average Revenue over 5 years is $112789.6, with a median of $36031.0 recorded in 2024.
  • Year-over-year, Revenue jumped 874.31% in 2022 and slumped 95.58% in 2023.
  • Tracing NXL's Revenue over 5 years: stood at $38424.0 in 2022, then slumped by 46.55% to $20536.0 in 2023, then surged by 32.35% to $27179.0 in 2024, then surged by 532.46% to $171895.0 in 2025, then slumped by 91.3% to $14950.0 in 2026.
  • The last three Revenue figures came in at $14950.0 (Q1 2026), $171895.0 (Q4 2025), and $18149.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 11.16 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.02 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.02 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 5.20 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.65 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.57 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.19 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.59 Bn
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 14,950.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 14,950.00
Dec 31, 2025 171,895.00
Sep 30, 2025 18,149.00
Jun 30, 2025 70,588.00
Mar 31, 2025 41,015.00
Dec 31, 2024 27,179.00
Sep 30, 2024 36,031.00
Jun 30, 2024 26,840.00
Mar 31, 2024 78,671.00
Dec 31, 2023 20,536.00
Sep 30, 2023 24,113.00
Jun 30, 2023 35,540.00
Mar 31, 2023 30,560.00
Dec 31, 2022 38,424.00
Sep 30, 2022 545,323.00
Jun 30, 2022 414,288.00
Mar 31, 2022 323,322.00
Dec 31, 2021 23,999.00
Sep 30, 2021 55,970.00